Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
"We expect that if we address the obesity issue in this country, then in theory, it should create savings down the road for cardiovascular conditions, liver conditions and kidney conditions," he said
It provides a more stable, sustained presence of the peptide in the bloodstream rather than a rapid peak and fall, potentially allowing for a more prolonged therapeutic window
Tirzepatide is a dual agonist that targets glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
EBM Consult
US$ 22.87
US$ 27.47
US$ 26.47
US$ 26.13
US$ 20.15
